RxDoctor Payments Data

Sakthivel Rajan Rajaram Manoharan

Orthopaedic Surgery · Birmingham, ALNPI 1356764765

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Cerapedics Inc. at 27.1% of the total. Reporting peaked in 2021 at $4,606 and has fallen 70.2% since, to $1,375 in 2025.

$15,653in general payments, 2019–2025

Across 113 payments — averaging $138.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cerapedics Inc.$4K
  • Synthes GmbH$4K
  • Medical Device Business Services, Inc.$3K
  • Johnson & Johnson$1K
  • Stryker$776
  • Globus Medical$743
  • plus $2K from 21 others
$65,462in research payments, 2019–2025

Across 3 payments — averaging $21,821 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cerapedics Inc.$50K
  • Stryker$15K

What the payments were for

  • Consulting fees$2,92519%
  • Speaking & faculty fees$3,25021%
  • Travel & lodging$3,17820%
  • Food & beverage$6,22340%
  • Education$770%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,653 in reported general payments places this provider in the 80th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$217,215
Medicare patients
141
Services billed
560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin87$863
Methocarbamol50$710
Pregabalin32$507
Cyclobenzaprine Hcl77$329
Oxycodone Hcl41$241
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$187
Tramadol Hcl39$153

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →